Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GISSELBRECHT, Christian")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 55

  • Page / 3
Export

Selection :

  • and

Use of rituximab in diffuse large B-cell lymphoma in the salvage settingGISSELBRECHT, Christian.British journal of haematology. 2008, Vol 143, Num 5, pp 607-621, issn 0007-1048, 15 p.Article

Traitement des lymphomes non hodgkiniens T périphériques = Treatment of peripheral T cell non-hodgkin lymphomaGISSELBRECHT, Christian.Hématologie (Montrouge). 2000, Vol 6, Num SEP, pp 13-15, issn 1264-7527, NSConference Paper

Anticorps monoclonaux dans le traitement des lymphomes : Lymphomes de l'adulte = Monoclonal antibodies in the treatment of lymphoma : Lymphomas in the adultMOUNIER, Nicolas; GISSELBRECHT, Christian.La Revue du praticien (Paris). 2002, Vol 52, Num 9, pp 982-985, issn 0035-2640Article

Rituximab: Enhancing outcome of autologous stem cell transplantation in non-Hodgkin's lymphomaGISSELBRECHT, Christian; MOUNIER, Nicolas.Seminars in oncology. 2003, Vol 30, Num 1, pp 28-33, issn 0093-7754, 6 p., SUP2Article

Analyse de la qualité de vie : effet sur les fonctions cognitives = Measuring the quality of life : effect on cognitive functionsGISSELBRECHT, Christian; HABABOU, Cyrla.Hématologie (Montrouge). 2003, Vol 9, Num 3, pp 11-14, issn 1264-7527, 4 p., NSConference Paper

Hodgkin's lymphoma : new treatment ideas for an old diseaseGISSELBRECHT, Christian.European journal of cancer. Supplement (1990). 2005, Vol 3, Num 3, pp 407-410, issn 1359-6349, 4 p.Conference Paper

Modern management of non-Hodgkin lymphoma in HIV-infected patientsMOUNIER, Nicolas; SPINA, Michele; GISSELBRECHT, Christian et al.British journal of haematology. 2007, Vol 136, Num 5, pp 685-698, issn 0007-1048, 14 p.Article

Improving second-line therapy in aggressive non-Hodgkin's lymphomaGISSELBRECHT, Christian; MOUNIER, Nicolas.Seminars in oncology. 2004, Vol 31, pp 12-16, issn 0093-7754, 5 p., SUP2Article

Advances in the understanding and management of angioimmunoblastic T-cell lymphomaDE LEVAL, Laurence; GISSELBRECHT, Christian; GAULARD, Philippe et al.British journal of haematology. 2010, Vol 148, Num 5, pp 673-689, issn 0007-1048, 17 p.Article

Autologous stem cell transplantation in lymphomaSCHMITZ, Norbert; BUSKE, Christian; GISSELBRECHT, Christian et al.Seminars in hematology. 2007, Vol 44, Num 4, pp 234-245, issn 0037-1963, 12 p.Article

High-dose therapy for indolent lymphomaMOUNIER, Nicolas; SOCIE, Gérard; GISSELBRECHT, Christian et al.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 225-239, issn 1040-8428Article

Les intensifications thérapeutiques avec autogreffe dans les lymphomes non hodgkiniens = Intensification with autologous transplantation in non-Hodgkin's lymphomasBOSLY, André; GISSELBRECHT, Christian.Bulletin du cancer. 2001, Vol 88, Num 9, pp 877-887, issn 0007-4551Article

Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trialsMOURAD, Nathalie; MOUNIER, Nicolas; DIEBOLD, Jacques et al.Blood. 2008, Vol 111, Num 9, pp 4463-4470, issn 0006-4971, 8 p.Article

Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma : Results of a western series of 48 patients treated with first-line polychemotherapy within the groupe d'Etude des lymphomes de l'Adulte (GELA) trialsBOSSARD, Celine; BELHADJ, Karim; RIBRAG, Vincent et al.Blood. 2007, Vol 109, Num 5, pp 2183-2189, issn 0006-4971, 7 p.Article

Respective prognostic values of germinal center phenotype and early 18fluorodeoxyglucose -positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphomaDUPUIS, Jehan; GAULARD, Philippe; MEIGNAN, Michel et al.Haematologica (Roma). 2007, Vol 92, Num 6, pp 778-783, issn 0390-6078, 6 p.Article

AIDS-related non-Hodgkin lymphoma : final analysis of 485 patients treated with risk-adapted intensive chemotherapy. CommentarySTRAUS, David J; MOUNIER, Nicolas; CHICHINO, Guido et al.Blood. 2006, Vol 107, Num 10, issn 0006-4971, 3819-3820,3832-3840 [11 p.]Article

Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progressionZHAO, Wei-Li; MOURAH, Samia; BRIERE, Josette et al.Laboratory investigation. 2004, Vol 84, Num 11, pp 1512-1519, issn 0023-6837, 8 p.Article

Human immunodeficiency virus-related lymphoma: Relation between clinical features and histologic subtypesGABARRE, Jean; RAPHAEL, Martine; SCHLAIFER, Daniel et al.The American journal of medicine. 2001, Vol 111, Num 9, pp 704-711, issn 0002-9343Article

Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell LymphomaHESS, Georg; HERBRECHT, Raoul; HANUSHEVSKY, Orysia et al.Journal of clinical oncology. 2009, Vol 27, Num 23, pp 3822-3829, issn 0732-183X, 8 p.Article

The impact of pre-and post-transplantation positron emission tomography using 18 -fluorodeoxyglucose on poor-prognosis lymphoma patients undergoing autologous stem cell transplantationFILMONT, Jean-Emmanuel; GISSELBRECHT, Christian; MOUNIER, Nicolas et al.Cancer. 2007, Vol 110, Num 6, pp 1361-1369, issn 0008-543X, 9 p.Article

Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma : A study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)FERME, Christophe; MOUNIER, Nicolas; REMAN, Oumedaly et al.Blood. 2006, Vol 107, Num 12, pp 4636-4642, issn 0006-4971, 7 p.Article

Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphomaZHAO, Wei-Li; DANESHPOUY, Marjan Ertault; JANIN, Anne et al.Blood. 2004, Vol 103, Num 2, pp 695-697, issn 0006-4971, 3 p.Article

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patientsANDRE, Marc; MOUNIER, Nicolas; HAIOUN, Corinne et al.Blood. 2004, Vol 103, Num 4, pp 1222-1228, issn 0006-4971, 7 p.Article

Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)MOUNIER, Nicolas; BRIERE, Josette; BOUABDALLAH, Reda et al.Blood. 2003, Vol 101, Num 11, pp 4279-4284, issn 0006-4971, 6 p.Article

Efficacy and Toxicity of 2 Schedules of Frontline Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Plus Bortezomib in Patients With B-Cell Lymphoma: A Randomized Phase 2 Trial From the French Adult Lymphoma Study Group (GELA)RIBRAG, Vincent; GISSELBRECHT, Christian; HAIOUN, Corinne et al.Cancer. 2009, Vol 115, Num 19, pp 4540-4546, issn 0008-543X, 7 p.Article

  • Page / 3